MedTech News

Bracco Diagnostics Inc. Branded Max 3™, a Rapid Exchange and Syringeless Injector, received FDA 510(k) clearance adding evolving innovation in Magnetic Resonance Imaging (MRI) and its product portfolio
PRINCETON, N.J., Dec. 2, 2024 /PRNewswire/ — Bracco Diagnostics Inc., the U.S. subsidiary of Bracco Imaging S.p.A., a leading global company in the diagnostic imaging business, along with ulrich GmbH & Co. KG, a renowned German medical device manufacturer specializing in contrast media injectors and spinal implants, announced today the clearance of the Bracco branded Max 3™, a Rapid Exchange and Syringeless Injector for use in magnetic resonance imaging (MRI) procedures.

Movano Health Receives FDA Clearance for EvieMED Ring
PLEASANTON, Calif., Dec. 2, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for the pulse oximeter in its EvieMED Ring.

Mediplus unveils ‘groundbreaking’ 5-way TIVA Set
Mediplus, a leader in medical device innovation, has unveiled its pioneering 5-Way TIVA Set at SIVA 2024, the annual scientific meeting hosted by The Society for Intravenous Anaesthesia.

Meril launches new heart valve technology for enhanced precision and accurate placements
The device is set to debut at the upcoming GISE 2024 and London Valves 2024 conferences.

Canon Medical unveils new advanced AI-powered MRI system
Canon Medical Systems USA today announced the commercial launch of its Vantage Galan 3T/Supreme Edition MRI system.

GE HealthCare unveils new mammography system
GE HealthCare (Nasdaq:GEHC) today announced its new Pristina Via mammography system designed to enhance the screening experience.

Ultromics obtains FDA clearance for Cardiac Amyloidosis screening device
EchoGo Amyloidosis is an AI-based software-only medical device, which aims to improve early detection of Cardiac Amyloidosis, an underdiagnosed cause of heart failure.

Zimmer wins FDA approval for cementless partial knee implant
The device has sold well in Europe, where the company said it has a 60% market share, but will be the first product of its type available in the U.S.